Total Payments
$10,842
2024 Payments
$1,783
Companies
32
Transactions
457
Medicare Patients
40,511
Medicare Billing
$3.0M
Payment Breakdown by Category
Food & Beverage$10,542 (97.2%)
Education$299.63 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,542 | 451 | 97.2% |
| Education | $299.63 | 6 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,974 | 191 | $0 (2024) |
| Janssen Biotech, Inc. | $1,056 | 65 | $0 (2024) |
| GENZYME CORPORATION | $887.99 | 38 | $0 (2024) |
| Lilly USA, LLC | $750.69 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $604.16 | 22 | $0 (2024) |
| LEO Pharma Inc. | $494.15 | 19 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $416.70 | 4 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $379.91 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $310.95 | 13 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $285.54 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,783 | 74 | ABBVIE INC. ($502.39) |
| 2023 | $1,830 | 76 | ABBVIE INC. ($617.13) |
| 2022 | $1,864 | 74 | ABBVIE INC. ($658.18) |
| 2021 | $1,050 | 56 | AbbVie Inc. ($476.42) |
| 2020 | $342.84 | 22 | AbbVie Inc. ($191.33) |
| 2019 | $1,340 | 52 | AbbVie, Inc. ($589.28) |
| 2018 | $1,520 | 58 | AbbVie, Inc. ($717.20) |
| 2017 | $1,114 | 45 | Janssen Scientific Affairs, LLC ($316.71) |
All Payment Transactions
457 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.49 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Immunology | ||||||
| 10/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Immunology | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.54 | General |
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Immunology | ||||||
| 08/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.39 | General |
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $104.72 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 10,383 | 15,881 | $3.5M | $766,495 |
| 2022 | 25 | 10,398 | 15,718 | $3.5M | $770,381 |
| 2021 | 27 | 10,263 | 15,625 | $3.3M | $764,737 |
| 2020 | 27 | 9,467 | 14,298 | $2.2M | $648,416 |
Total Patients
40,511
Total Services
61,522
Medicare Billing
$3.0M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 601 | 851 | $246,163 | $52,533 | 21.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 315 | 396 | $140,444 | $33,310 | 23.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 337 | 426 | $90,657 | $17,584 | 19.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 103 | 243 | $70,101 | $17,137 | 24.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2021 | 492 | 534 | $70,918 | $16,473 | 23.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 196 | 214 | $71,779 | $16,106 | 22.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 173 | 191 | $63,147 | $14,957 | 23.7% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Office | 2021 | 22 | 115 | $40,135 | $9,834 | 24.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 223 | 259 | $45,883 | $9,700 | 21.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 241 | 1,241 | $26,248 | $6,149 | 23.4% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 38 | 43 | $22,785 | $5,177 | 22.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 59 | 59 | $21,169 | $4,073 | 19.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 47 | 51 | $18,616 | $3,605 | 19.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 38 | $15,600 | $3,237 | 20.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 41 | 46 | $11,744 | $2,776 | 23.6% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 44 | 63 | $10,774 | $2,612 | 24.2% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Office | 2021 | 22 | 23 | $10,580 | $2,594 | 24.5% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2021 | 15 | 24 | $7,920 | $1,959 | 24.7% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 21 | 21 | $4,914 | $959.12 | 19.5% |
| 69100 | Biopsy of ear | Office | 2021 | 13 | 13 | $4,160 | $844.16 | 20.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 39 | 76 | $3,526 | $777.45 | 22.0% |
| 11200 | Removal of up to and including 15 skin tags | Office | 2021 | 12 | 12 | $3,475 | $635.40 | 18.3% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Office | 2021 | 32 | 32 | $1,601 | $354.46 | 22.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 41 | 365 | $8,757 | $339.71 | 3.9% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2021 | 14 | 15 | $285.00 | $87.45 | 30.7% |
About Dr. Martha Mccollough, MD
Dr. Martha Mccollough, MD is a Dermatology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972530954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martha Mccollough, MD has received a total of $10,842 in payments from pharmaceutical and medical device companies, with $1,783 received in 2024. These payments were reported across 457 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($10,542).
As a Medicare-enrolled provider, Mccollough has provided services to 40,511 Medicare beneficiaries, totaling 61,522 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Tyler, TX
- Active Since 06/27/2006
- Last Updated 05/22/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1972530954
Products in Payments
- SKYRIZI (Biological) $1,249
- DUPIXENT (Biological) $1,187
- RINVOQ (Biological) $1,126
- Humira (Biological) $945.92
- TREMFYA (Drug) $914.27
- TALTZ (Drug) $750.69
- STELARA (Biological) $263.37
- Sotyktu (Drug) $253.06
- ENSTILAR (Drug) $239.64
- ADBRY (Biological) $200.00
- COSENTYX (Biological) $179.89
- Tremfya (Drug) $150.40
- Skyrizi (Biological) $144.54
- SURGIPRO LL (Device) $144.18
- Erivedge (Biological) $138.58
- RHOFADE (Drug) $134.99
- LIBTAYO (Biological) $127.77
- CIBINQO (Drug) $119.06
- Zoryve (Drug) $115.42
- OPDIVO (Biological) $112.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Tyler
Jennifer Holman, Md, MD
Dermatology — Payments: $705,235
Dermatology $705,235
Lindsey Hunter-Ellul, Md, MD
Dermatology — Payments: $11,358
Dermatology $11,358
Leslie Markle, Md, MD
Dermatology — Payments: $8,660
Dermatology $8,660
Alma Berlingeri Ramos, Md, MD
Dermatology — Payments: $4,757
Dermatology $4,757
Jeffrey Harbold, Do, DO
Dermatology — Payments: $4,013
Dermatology $4,013
Bradley Graham, Md, MD
Dermatology — Payments: $3,625
Dermatology $3,625